Skip to content

Effect of oral probiotic lactofem on metabolic parameters in overweight pregnant women referred to prenatal clinics of the shiraz hospitals in 2016

Effect of oral probiotic lactofem on metabolic parameters in overweight pregnant women referred to prenatal clinics of the shiraz hospitals in 2016

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161025030502N2
Enrollment
144
Registered
2018-02-04
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Certain conditions originating in the perinatal period. Other specified conditions originating in the perinatal period

Interventions

Intervention 1: In the intervention group one probiotic capsule every 12 hours be administered Of the week 20 to 36 of pregnancy. Intervention 2: Case-control study. In the control group one placebo

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Tendency to participate in research pre-pregnancy body mass index between 25 > BMI> 30 (which is selected by questionnaire) 20 to 24 weeks gestational age The lack of any disease, including diabetes, high blood pressure, liver disease, kidney, adrenal and thyroid, Hypercholesterolemia and bleeding Do not use medications that affect glucose metabolism and fat and blood pressure normal diet (based on questionnaires is selected) non-smoking

Exclusion criteria

Exclusion criteria: No proper use of probiotics any allergies to medication or placebo The occurrence of acute bleeding pre-eclampsia

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar-Fasting glucose and blood sugar 2 hours after breakfast. Timepoint: 20 week before intervention,28 and 36 week, after intervention. Method of measurement: Blood sample.;Systolic and diastolic blood pressure. Timepoint: 20 week before intervention,28 and 36 week, after intervention. Method of measurement: Blood sample.;Plasma lipids. Timepoint: 20 week before intervention,28 and 36 week, after intervention. Method of measurement: Blood sample.

Secondary

MeasureTime frame
Reduce the blood sugar. Timepoint: 20 week before intervention,28 -36 week after intervention. Method of measurement: ????? ???.;Reduce the blood pressure. Timepoint: 20 week before intervention,28 -36 week after intervention. Method of measurement: mercury manometer.;Reduce the serum lipids. Timepoint: 20 week before intervention,28 -36 week after intervention. Method of measurement: ????? ???.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Azima

School of Nursing and Midwifery, Shiraz University of Medical Siences

azimas@sums.ac.ir+98 917 300 9450

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026